M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 34.2 SEK -1.16% Market Closed
Market Cap: 629.3m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Cost of Revenue Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
MCAP

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Cost of Revenue
-kr16.5m
CAGR 3-Years
18%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Cost of Revenue
-kr6B
CAGR 3-Years
-21%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cost of Revenue
-kr1.1B
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cost of Revenue
-kr794m
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
Genovis AB
STO:GENO
Cost of Revenue
-kr45.2m
CAGR 3-Years
-43%
CAGR 5-Years
-64%
CAGR 10-Years
-12%
MedCap AB (publ)
STO:MCAP
Cost of Revenue
-kr954.9m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
-4%

See Also

What is Magle Chemoswed Holding AB's Cost of Revenue?
Cost of Revenue
-16.5m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Cost of Revenue amounts to -16.5m SEK.

What is Magle Chemoswed Holding AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%

Over the last year, the Cost of Revenue growth was -46%. The average annual Cost of Revenue growth rates for Magle Chemoswed Holding AB have been 18% over the past three years , -6% over the past five years .

Back to Top